Author Archives: Mary Reinen

2018 Spring Cardiovascular Symposium

Intended Audience:

Physicians and other healthcare professionals This  live symposium is intended to benefit internists, cardiologists, family medicine physicians, podiatrists, oncologists, radiologists, NPs, PAs, APNs, RNs and other healthcare providers.

Objectives:

  • Be aware of developments in revascularization techniques of coronary artery disease, both percutaneous and surgical
  • Discuss the latest updates regarding antiplatelet therapies
  • Utilize the latest strategies on the management of atrial fibrillation
  • Compare anticoagulation options for thromboprophylaxis for atrial fibrillation, including left atrial appendage closure devices
  • Be familiar with screening, diagnosis and treatment options for carotid artery disease
  • Be familiar with screening, diagnosis and treatment options for abdominal aortic aneurysms
  • Be aware of the latest developments and techniques to tackle structural heart disease, including identifying patients suitable for Transcatheter Aortic Valve Replacement (TAVR)
  • Review the screening, diagnosis and management of peripheral vascular disease, including lower extremity arterial and venous disease

LOCATION
Centegra Hospital – Huntley
10400 Haligus Rd.
Huntley, IL 60142

AVAILABLE DATES
Wednesday, April 25th, 2018
4:30p – 9:30p
Dinner Included
OR
Thursday, April 26th, 2018
7:30a – 12:30p
Breakfast Included

COST
Online registration receives a $10 discount
MD/DO/FP/DC                            $70
PA/NP/APN                                  $70
RN/Others                                     $50
PT/OT                                             $50
VISA & MasterCard accepted as well as a CHS Cost Center.

REGISTRATION
To register, please click here.

ADDITIONAL INFORMATION
For additional information, please contact Edie Best.

Potassium Chloride Injection Shortage

We have been alerted by Pfizer Inc. that Potassium Chloride Injection will experience a supply interruption due to Hurricane Maria and the inability of their other manufacturing plants to keep up with demand. The Pharmaceutical Purchasing Group at CHS checks for supply on a daily basis. While we expect some supply to arrive this week, our stock is very low at this time. Please consider the use of oral potassium products wherever possible. Potassium Acetate and Potassium Phosphate riders are an alternative in appropriate patients. In addition, Large Volume Parenteral Products (D5% – 0.2% NS with KCL, D5%-0.45% with KCL and D5% – 0.9% NS with KCL) are other alternatives.

Thank you for your assistance during this shortage.